Pulmonary artery enlargement predicts exacerbation in COPD

Pulmonary artery enlargement predicts exacerbation in COPD
For patients with chronic obstructive pulmonary disease, computed tomographic measurement of pulmonary artery enlargement, as determined by a ratio of the diameter of the pulmonary artery to the diameter of the aorta of >1, correlates with severe exacerbations, according to a study published online Sept. 3 in the New England Journal of Medicine to coincide with presentation at the annual meeting of the European Respiratory Society, held from Sept. 1 to 5 in Vienna.

(HealthDay)—For patients with chronic obstructive pulmonary disease (COPD), computed tomographic (CT) measurement of pulmonary artery enlargement, as determined by a ratio of the diameter of the pulmonary artery to the diameter of the aorta (PA:A) of >1, correlates with severe exacerbations, according to a study published online Sept. 3 in the New England Journal of Medicine to coincide with presentation at the annual meeting of the European Respiratory Society, held from Sept. 1 to 5 in Vienna.

J. Michael Wells, M.D., from the University of Alabama at Birmingham, and colleagues conducted a multicenter observational trial involving former and current smokers with COPD to determine the association between a PA:A ratio of >1 and a history of severe exacerbations requiring hospitalization at the time of enrollment. The utility of the ratio was assessed as a predictor of events in longitudinal follow-up of this cohort and in an external validation cohort.

The researchers observed a significant association between a PA:A ratio of >1 and a history of severe exacerbations (odds ratio, 4.78). In both the trial cohort and the external validation cohort, a PA:A ratio of >1 correlated independently with an increased risk of future severe exacerbations (odds ratio, 3.44 and 2.80, respectively). PA:A ratio of >1 had the strongest association with severe exacerbations of all the variables analyzed.

"Pulmonary artery enlargement (a PA:A ratio of >1), as detected by CT, was associated with severe of COPD," Wells and colleagues conclude.

Several authors disclosed with pharmaceutical and biotechnology companies.

More information: Abstract
Full Text
Editorial
More Information

Related Stories

Recommended for you

Obama to announce major Ebola effort

6 hours ago

US President Barack Obama will Tuesday seek to "turn the tide" in the Ebola epidemic by ordering 3,000 US military personnel to West Africa and launching a major health care training and hygiene program.

Sierra Leone: WHO too slow to help doc with Ebola

16 hours ago

Sierra Leone accused the World Health Organization on Monday of being "sluggish" in facilitating an evacuation of a doctor who died from Ebola before she could be sent out of the country for medical care.

Dutch doctors feared to have Ebola leave hospital

16 hours ago

Two Dutch doctors flown home from west Africa after fears they might have been contaminated with the killer Ebola virus have left hospital "in good health," their employer, the Lion Heart Medical Centre, said Monday.

Strategic self-sabotage? MRSA inhibits its own growth

21 hours ago

Scientists at the University of Western Ontario have uncovered a bacterial mystery. Against all logic, the most predominant strain of methicillin-resistant Staphylococcus aureus (MRSA) in North American produces an enzyme ...

User comments